PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brheartjLink to Publisher's site
 
Br Heart J. 1995 December; 74(6): 636–640.
PMCID: PMC484120

Effect of low dose sotalol on the signal averaged P wave in patients with paroxysmal atrial fibrillation.

Abstract

OBJECTIVE--To investigate the effects of low dose sotalol on the signal averaged surface P wave in patients with paroxysmal atrial fibrillation. DESIGN--A longitudinal within patient crossover study. SETTING--Cardiac departments of a regional cardiothoracic centre and a district general hospital. PATIENTS--Sixteen patients with documented paroxysmal atrial fibrillation. The median (range) age of the patients was 65.5 (36-70) years; 11 were men. MAIN OUTCOME MEASURES--Analysis of the signal averaged P wave recorded from patients not receiving antiarrhythmic medication and after 4-6 weeks' treatment with sotalol. P wave limits were defined automatically by a computer algorithm. Filtered P wave duration and energies contained in frequency bands from 20, 30, 40, 60, and 80 to 150 Hz of the P wave spectrum expressed as absolute values (P20, P30, etc) and as ratios of high to low frequency energy (PR20, PR30, etc) were measured. RESULTS--No difference in P wave duration was observed between the groups studied (mean (SEM) 149 (4) without medication and 152 (3) ms with sotalol). Significant decreases in high frequency P wave energy (for example P60: 4.3 (0.4) v 3.3 (0.3) microV2.s, P = 0.003) and energy ratio (PR60: 5.6 (0.5) v 4.7 (0.6), P = 0.03) were observed during sotalol treatment. These changes were independent of heart rate. CONCLUSIONS--Treatment with low dose sotalol reduces high frequency P wave energy but does not change P wave duration. These results are consistent with the class III effect of the drug and suggest that signal averaging of the surface P wave may be a useful non-invasive measure of drug induced changes in atrial electrophysiology.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (862K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Engel TR, Vallone N, Windle J. Signal-averaged electrocardiograms in patients with atrial fibrillation or flutter. Am Heart J. 1988 Mar;115(3):592–597. [PubMed]
  • Kawano S, Hiraoka M, Sawanobori T. Electrocardiographic features of P waves from patients with transient atrial fibrillation. Jpn Heart J. 1988 Jan;29(1):57–67. [PubMed]
  • Opolski G, Stanisławska J, Słomka K, Kraska T. Value of the atrial signal-averaged electrocardiogram in identifying patients with paroxysmal atrial fibrillation. Int J Cardiol. 1991 Mar;30(3):315–319. [PubMed]
  • Stafford PJ, Turner I, Vincent R. Quantitative analysis of signal-averaged P waves in idiopathic paroxysmal atrial fibrillation. Am J Cardiol. 1991 Sep 15;68(8):751–755. [PubMed]
  • Baciarello G, Bella R, Di Maio F, Sgrigna V, Villani M, Campbell SV, Sciacca A. Analysis of high-resolution atrial activation: report on 403 cases. Am Heart J. 1987 Feb;113(2 Pt 1):307–315. [PubMed]
  • Yamada T, Fukunami M, Ohmori M, Kumagai K, Sakai A, Kondoh N, Minamino T, Hoki N. Characteristics of frequency content of atrial signal-averaged electrocardiograms during sinus rhythm in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol. 1992 Mar 1;19(3):559–563. [PubMed]
  • Leier CV, Meacham JA, Schaal SF. Prolonged atrial conduction. A major predisposing factor for the development of atrial flutter. Circulation. 1978 Feb;57(2):213–216. [PubMed]
  • Buxton AE, Waxman HL, Marchlinski FE, Josephson ME. Atrial conduction: effects of extrastimuli with and without atrial dysrhythmias. Am J Cardiol. 1984 Oct 1;54(7):755–761. [PubMed]
  • Cosio FG, Palacios J, Vidal JM, Cocina EG, Gómez-Sánchez MA, Tamargo L. Electrophysiologic studies in atrial fibrillation. Slow conduction of premature impulses: a possible manifestation of the background for reentry. Am J Cardiol. 1983 Jan 1;51(1):122–130. [PubMed]
  • Stafford PJ, Robinson D, Vincent R. Optimal analysis of the signal averaged P wave in patients with paroxysmal atrial fibrillation. Br Heart J. 1995 Oct;74(4):413–418. [PMC free article] [PubMed]
  • Stafford P, Denbigh P, Vincent R. Frequency analysis of the P wave: comparative techniques. Pacing Clin Electrophysiol. 1995 Feb;18(2):261–270. [PubMed]
  • Strauss HC, Bigger JT, Jr, Hoffman BF. Electrophysiologial and beta-receptor blocking effects of MJ 1999 on dog and rabbit cardiac tissue. Circ Res. 1970 Jun;26(6):661–678. [PubMed]
  • Echt DS, Berte LE, Clusin WT, Samuelsson RG, Harrison DC, Mason JW. Prolongation of the human cardiac monophasic action potential by sotalol. Am J Cardiol. 1982 Nov;50(5):1082–1086. [PubMed]
  • Hayward RP, Taggart P. Effect of sotalol on human atrial action potential duration and refractoriness: cycle length dependency of class III activity. Cardiovasc Res. 1986 Feb;20(2):100–107. [PubMed]
  • Bennett DH. Acute prolongation of myocardial refractoriness by sotalol. Br Heart J. 1982 Jun;47(6):521–526. [PMC free article] [PubMed]
  • Kunze KP, Schlüter M, Kuck KH. Sotalol in patients with Wolff-Parkinson-White syndrome. Circulation. 1987 May;75(5):1050–1057. [PubMed]
  • Cobbe SM, Hoffman E, Ritzenhoff A, Brachmann J, Kübler W, Senges J. Action of sotalol on potential reentrant pathways and ventricular tachyarrhythmias in conscious dogs in the late postmyocardial infarction phase. Circulation. 1983 Oct;68(4):865–871. [PubMed]
  • Funck-Brentano C, Kibleur Y, Le Coz F, Poirier JM, Mallet A, Jaillon P. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans. Circulation. 1991 Feb;83(2):536–545. [PubMed]
  • Piccolo E, Raviele A, Delise P, Dainese F, Pascotto P, Totaro G, Sartori F, D'Este D. The role of left ventricular conduction in the electrogenesis of left ventricular hypertrophy. An electrophysiologic study in man. Circulation. 1979 May;59(5):1044–1055. [PubMed]
  • David D, Naito M, Michelson E, Watanabe Y, Chen CC, Morganroth J, Shaffenburg M, Blenko T. Intramyocardial conduction: a major determinant of R-wave amplitude during acute myocardial ischemia. Circulation. 1982 Jan;65(1):161–167. [PubMed]
  • Freedman RA, Karagounis LA, Steinberg JS. Effects of sotalol on the signal-averaged electrocardiogram in patients with sustained ventricular tachycardia: relation to suppression of inducibility and changes in tachycardia cycle length. J Am Coll Cardiol. 1992 Nov 1;20(5):1213–1219. [PubMed]
  • Wang T, Bergstrand RH, Thompson KA, Siddoway LA, Duff HJ, Woosley RL, Roden DM. Concentration-dependent pharmacologic properties of sotalol. Am J Cardiol. 1986 May 1;57(13):1160–1165. [PubMed]

Articles from British Heart Journal are provided here courtesy of BMJ Group